PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Por um escritor misterioso
Descrição
Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Regulatory Effects and Molecular Mechanisms of Tea and Its Active Compounds on Nonalcoholic Fatty Liver Disease
Full article: Statin-induced myopathy: a review and update
Evaluating the efficacy and timing of blood purification modalities in early-stage hyperlipidemic acute pancreatitis treatment, Lipids in Health and Disease
Frontiers Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
Muscle- and skeletal-related side-effects of statins: tip of the iceberg? - Johann Auer, Helmut Sinzinger, Barry Franklin, Robert Berent, 2016
PDF) Narrative Review: Statin-Related Myopathy
Hypertriglyceridemia: Practice Essentials, Pathophysiology, Etiology
PDF) Statin-induced myopathy: A review and update
Myopathy with statin-fibrate combination therapy: clinical considerations - Document - Gale OneFile: Health and Medicine
Muscle Toxicity of Drugs: When Drugs Turn Physiology into Pathophysiology
Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference - Canadian Journal of Cardiology
Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy
Statin protects men but not women with HIV against loss of muscle mass, strength, and physical function: a pilot study
de
por adulto (o preço varia de acordo com o tamanho do grupo)